DELIC Jozo :: CEA/IRCM :: Cancérologie Expérimentale Unité de

DELIC Jozo :: CEA/IRCM :: Cancérologie Expérimentale
Unité de recherche : CEA Fontenay-aux-Roses :
CEA Fontenay-aux-Roses
Institut de Radiobiologie Cellulaire et Moléculaire (IRCM)
Service de Radiologie et Innovation Technologique
18 av du Panorama
92265 Fontenay-aux-Roses cedex
Directeur de l'unité de rattachement : : Sylvie CHEVILLARD
Responsable de l'équipe de recherche :
DELIC Jozo
Courriel : [email protected]
Tel: 01 46 54 81 19
Composition de l'équipe de recherche : :
CHEVILLARD Sylvie (DR, HDR)
DELIC Jozo (DR, HDR)
GRALL Romain (CR)
GOISLARD Maud (IR)
GUILLY Marie-Noelle (CR)
LEBEAU Jérôme (DR, HDR)
MOREL-ALTMEYER Sandrine (IR)
ORY Cathy (CR)
UGOLIN Nicolas (CR, HDR)
5 publications récentes et significatives de l'équipe de recherche : :
Bouley J, Saad L, Grall R, Schellenbauer A, Biard D, Paget V, Morel-Altmeyer, S, Guipaud O, Chambon C, Salles B,
Maloum K, Merle-Béral H, Chevillard 0 and Delic J. A phosphorylated form of Ku70 confers resistance to
chemotherapy in chronic lymphocytic leukemia through fast but unfaithful DNA repair. Oncotarget, 2015,
sep29;6(29):27980-8000
Grall, R., Girard, H., Saad, L., Petit, T., Gesset, C., Combis-Schlumberger, M., Paget, V., Delic, J., Arnault, J-C.,
Chevillard, S. Hydrogenated nanodiamonds combined with g-irradiation drive resistant cancer cells into senescence.
Biomaterials, 2015,Aug, 61:290-8
Brugat, T., F. Nguyen-Khac, A. Grelier, H. Merle-Beral, and J. Delic, Telomere dysfunction-induced foci arise with the
onset of telomeric deletions and complex chromosomal aberrations in resistant chronic lymphocytic leukemia cells.
Blood, 2010. 116(2): p. 239-49.
Brugat, T., N. Gault, I. Baccelli, J. Maes, A. Roborel de Climens, F. Nguyen-Khac, F. Davi, H. Merle-Beral, E. Gilson,
M. Goodhardt, and J. Delic, Aberrant telomere structure is characteristic of resistant chronic lymphocytic leukaemia
cells. Leukemia Research, 2010. 24(1): p. 246-51.
Review Chapter : "DNA Damge Response/Signaling and Genome (In)Stability as the New Reliable Biological
Parameters Defining Clinical Feature of CLL". J. Delic, J. Marteau, J-B Maloum, K. Nguyen-Khac, F. Davi, F. Azgui, Z;
Leblond, V. Binet, J-L Chevillard, S. Merle-Béral, H. OnLine Book "Chronic Lymphocytic Leukemia", 02/2012